Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962363 · ClinicalTrials.gov registry record · Phase 2
EPI-743 in Friedreich's Ataxia Point Mutations
A Phase 2 study of Friedreich's Ataxia, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT01962363: Completed Phase 2 study of Friedreich's Ataxia, sponsored by University of South Florida.
NCT01962363 is a Phase 2 study of Friedreich's Ataxia that has completed, run by University of South Florida. The registered enrollment target is 4 participants, below the 80-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01962363, a Phase 2 study of Friedreich's Ataxia, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Friedreich's Ataxia point mutations
Primary Outcome
Low contrast acuity
Conditions Studied
Interventions
- DRUG EPI-743
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
What the finished NCT01962363 record still lists
NCT01962363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 80-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Friedreich's Ataxia appearing as the primary indexed condition, and to 1 intervention - of which EPI-743 is the first listed.
NCT01962363 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01962363 about?
NCT01962363 is a clinical study titled "EPI-743 in Friedreich's Ataxia Point Mutations". The purpose of this study is to evaluate the effects of EPI-743 in patients with Friedreich's Ataxia point mutations
What is the current status of trial NCT01962363?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2013-10. Estimated completion is 2016-06.
What conditions does trial NCT01962363 study?
This clinical trial studies the following conditions: Friedreich's Ataxia.
What interventions are being tested in trial NCT01962363?
The interventions under investigation include: EPI-743 (DRUG).
Who is sponsoring clinical trial NCT01962363?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01962363 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich's Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers in Friedreich's Ataxia
RECRUITING
-
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
RECRUITING
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
COMPLETED · Phase 1
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
COMPLETED · Phase 1
-
Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia